Constellation Capital Corp. is a Canada-based capital pool company. The principal business of the Company is to identify and evaluate assets or businesses with a view to acquire them or an interest therein by completing a purchase transaction.

Employees

Sector

Investment Holding Companies

More about the company

Income Statement and Estimates

More financial data

Delayed Toronto S.E. Other stock markets 03:00:00 22/01/26 am AEDT			5-day change	1st Jan Change
0.0700 ^CAD	-.--%		-.--%	-

28/07	Constellation Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
12/05	Constellation Capital Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	476K 338K 294K 274K 252K 32.19M 481K 3.23M 1.26M 16.09M 1.27M 1.24M 53.32M	P/E 2024	-7.49x	P/E 2025	-8.26x
Enterprise Value	-150K -107K -92.75K -86.47K -79.44K -10.16M -152K -1.02M -399K -5.08M -401K -392K -16.83M	EV / Sales 2024	-	EV / Sales 2025	-
Free-Float	90.67%	Yield 2024 *	-	Yield 2025	-

28/07	Constellation Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
12/05	Constellation Capital Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
09/02	Active Witness Corp. entered into letter of intent to acquire Constellation Capital Corp. (TSXV:CNST.P) in a reverse merger transaction for CAD 16.4 million.	CI
30/01	Constellation Capital Corp. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12/11	Constellation Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
16/07/25	Constellation Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
24/04/25	Constellation Capital Corp. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
24/01/25	Constellation Capital Corp. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
17/01/25	1,300,000 Common Shares of Constellation Capital Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2025.	CI
17/01/25	300,000 Stock Options of Constellation Capital Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2025.	CI
30/10/24	Constellation Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
22/07/24	Constellation Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
20/07/24	1,300,000 Common Shares of Constellation Capital Corp. are subject to a Lock-Up Agreement Ending on 20-JUL-2024.	CI

03/04	Constellation Announces Extension to Amalgamation Agreement with Active Witness Corp.	AQ
10/02	Constellation Announces Proposed Acquisition of Active Witness Corp.	AQ
15/11	Constellation Announces Extension Of LOI For The Proposed Acquisition Of Active Witness Corp.	AQ
30/09/25	Constellation Announces Proposed Acquisition Of Active Witness Corp.	AQ
30/09/25	Canadian Investment Regulatory Organization Trading Halt - CNST.P	AQ

Constellation Capital Corp. Stock

Stocks

CNST.P

CA21036W1032

Investment Holding Companies

Valuation: Constellation Capital Corp.

Chart: Constellation Capital Corp.

Latest news : Constellation Capital Corp.

Press Releases: Constellation Capital Corp.

Course Extremes

Managers and Directors: Constellation Capital Corp.

Latest insider transactions

Shell Companies

Financials

Company Profile

Income Statement and Estimates

1 year	0.04	0.15
3 years	0.04	0.15
5 years	0.04	0.15
10 years	0.04	0.15

Director	Title	Age	Since
Dayton Marks BRD	Director/Board Member	33	27/07/2022
Roger Jewett BRD	Director/Board Member	63	01/01/2022
Robert Quinn BRD	Director/Board Member	70	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
10/12/24	Roger Jewett	Buy	Director	10,000	0.1471%
5/12/24	Roger Jewett	Buy	Director	50,000	0.7353%
5/12/24	Roger Jewett	Buy	Director	60,000	0.8824%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CONSTELLATION CAPITAL CORP.	-.--%	-.--%	+100.00%	-22.22%	338K
BOXABL INC.	-7.10%	+9.05%	-53.83%	-	13.38B
FREENOME, INC.	+0.36%	+3.53%	+5.49%	-	1.23B
CHURCHILL CAPITAL CORP XI	+0.49%	+16.20%	-	-	858M
CENTIEL AG	+5.92%	+11.84%	+309.64%	-64.95%	647M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.10%	0.00%	-	-	644M
CHURCHILL CAPITAL CORP XII	+2.35%	+2.64%	-	-	604M
BAIN CAPITAL GSS INVESTMENT CORP.	+0.10%	-0.39%	-	-	596M
CANTOR EQUITY PARTNERS IV, INC.	+0.10%	-0.10%	-	-	595M
Average	+0.40%	+1.96%	+90.32%	-43.59%	2.06B
Weighted average by Cap.	-4.57%	+11.77%	-33.63%	-64.93%

	2024	2025
Net sales	-	-
Net income	-45.38K -32.26K -28.01K -26.12K -24K -3.07M -45.88K -308K -120K -1.53M -121K -119K -5.08M	-57.62K -40.96K -35.57K -33.16K -30.47K -3.9M -58.25K -391K -153K -1.95M -154K -150K -6.45M
Net Debt	-679K -483K -419K -391K -359K -45.91M -686K -4.61M -1.8M -22.95M -1.81M -1.77M -76.04M	-626K -445K -387K -360K -331K -42.35M -633K -4.25M -1.66M -21.17M -1.67M -1.64M -70.15M